Full Text View
Tabular View
No Study Results Posted
Related Studies
The Effect of Concomitant Administration of Erythromycin and Diltiazem on CYP3A Activity in Healthy Volunteers
This study has been completed.
Study NCT00318201   Information provided by Indiana University
First Received: April 21, 2006   Last Updated: December 12, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Healthy
Interventions listed in this trial
Erythromycin
Diltiazem
Additional drug interventions recognized in this trial
Erythromycin Estolate
Erythromycin Ethylsuccinate
Erythromycin stearate
Verapamil
More general drug interventions related to this trial
Anti-Arrhythmia Agents
Anti-Bacterial Agents
Anti-Infective Agents
Antihypertensive Agents
Calcium Channel Blockers
Cardiovascular Agents
Enzyme Inhibitors
Gastrointestinal Agents
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protein Synthesis Inhibitors
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Indiana University School of Medicine


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services